// App-Quantinova.ai

AB0121 : DIFFERENTIAL EXPRESSION OF MICRORNAS IN MONOCYTES AND NEUTROPHILS FROM PRIMARY ANTIPHOSPHOLIPID SYNDROME AND SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS. POTENTIAL VALUE AS BIOMARKERS OF ATHEROTHROMBOTIC DISEASE

Researchers

Presenter

  • C. Perez-Sanchez

Principal Investigators

  • P. Ruiz-Limon

  • R. Teruel

  • C. Lopez-Pedrera

  • M. A. Aguirre

  • R. M. Carretero

  • N. Barbarroja

  • A. Rodriguez-Ariza

  • E. Collantes

  • M. J. Cuadrado

  • R. Gonzalez-Conejero

  • C. Martiez

Medical Centers

  • Guy's And St Thomas NHS Foundation Trust, London, United Kingdom

  • Regional Centre for Blood Donation, University of Murcia, Murcia, Spain

Locations

  • Spain

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Lupus

  • Antiphospholipid syndrome

  • Coronary Artery Disease

  • Venous thrombosis

Biomarkers

  • microRNA-155

  • C-C Motif Chemokine Ligand 2

  • Interleukin 10

  • Interleukin 6

  • Interleukin-2

  • Interleukin-8

Drug/Treatment

  • miR155

  • Interleukin-10

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved